CMG Pharmaceutical Co., Ltd. (058820.KQ) KOE

Currency In KRW

AD

Valuation

Market Cap274.69B
Enterprise Value340.58B
P/E Ratio-18.63
PEG Ratio0.01
Price/Sales Ratio1.28
Price/Book Ratio0.68
Enterprise/Revenue1.99
Enterprise/EBITDA10.76

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.07
Operating Margin-0.05
AD

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.04

Income Statement

Revenue105.23B
Revenue/Share763.49
Gross Profit59.45B
EBITDA-610.42M
Net Income-8.96B
Diluted EPS-60.63

Balance Sheet

Total Cash26.49B
Total Cash/Share183.63
Total Debt88.3B
Total Debt/Equity0.44
Current Ratio1.25
Book Value Per Share1,398.56

Price History

52-Week Change-53.77
52-Week High2,255
52-Week Low901
Moving Average 50 Days1,462.6
Moving Average 200 Days1,771.54

Statistics

Average Volume817,696
Shares Outstanding147.84M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1073:1000
Last Split DateJune 13, 2019
AD